The size of the Europe Interventional Neurology Market was worth USD 583.82 million in 2021 and estimated to reach USD 890.07 million by the end of 2026, with a growing potential of 8.80 %. Europe Interventional Neurology market is expected to account for the second-largest share in the market due to a favorable reimbursement scenario and advancements in technology.
Growing difficulties in treating the patients affecting by recurring stroke incidents, identification of advantages provided by interventional neurology methods, and approachability of medical reimbursement processes among the European countries are likely to fuel the market growth during the analysis period.
Also, neuro-interventional devices such as intravascular devices, stent retrievers, and flow diverters are considered significant asset popularity during the analysis time (2020-2025). The wide range of applications in identifying and treating several diseases in this interventional neurology field has increased extensively. The number of mergers and acquisitions that are happening between the market participants is growing, which is estimated to favor the market in this region.
The shortage of skilled and experienced neurosurgeons, strict regulatory bodies are likely to hamper the market growth during the period. The cost of the devices is so expensive which is one of the prime factors impeding the market growth in the interventional neurology market. Unacceptable regulatory schemes are hindering the market.
This market research report on the European Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories;
Regional Analysis:
Europe is expected to account for the second-largest share in the global market in 2019 and the market is driven by factors such as acceptable reimbursement policies and technological developments. An increase in the patient count with nerve-related disorders and considerable endorsement of neurovascular devices amid the neurosurgeons is propelling the market growth in the region during the analysis period. Increasing old people population, growing requirement for minimally invasive neurosurgical procedures as these devices assist in lessening discomfort, and loss of blood during the treatment time.
Germany is dominating the market with the highest share in the period because of different developments in technology in the healthcare sector and government funds in enhancing the healthcare infrastructure which fuels the market growth during the review period.
The UK is the next leading country in the region with share due to continuous development of product development and commodification, increasing requirement for neurovascular devices, durable existence of device producers in the area, and availability of significant research and development investments to help these neurovascular devices product development which accelerates the market growth during the estimated period. Escalating chronic diseases like blood vessel diseases and new procedures and their development like (OCT) Optical Coherence Tomography, Fractional Flow Reserve (FFR) are some prime factors mounting the Interventional Neurology market of Europe region.
Some of the key players in Europe Interventional Neurology Market are Stryker Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Microport Scientific Corporation, and Medikit Co., Ltd
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Embolization and Coiling
5.1.3 Angioplasty
5.1.4 Carotid Stenting
5.1.5 Neurothrombectomy
5.1.6 Micro support devices
5.1.7 Others
5.1.8 Y-o-Y Growth Analysis, By Technology
5.1.9 Market Attractiveness Analysis, By Technology
5.1.10 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Carotid Stent
5.2.3 Microcatheter
5.2.4 Flow Diversion
5.2.5 Microguidewires
5.2.6 Suction Device
5.2.7 stenting systems
5.2.8 Clot Retrieval
5.2.9 Others
5.2.10 Y-o-Y Growth Analysis, By Product
5.2.11 Market Attractiveness Analysis, By Product
5.2.12 Market Share Analysis, By Product
5.3 End-users
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Ambulatory centers
5.3.4 Neurology clinics
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By End-users
5.3.7 Market Attractiveness Analysis, By End-users
5.3.8 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By End-users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Stryker Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic plc
8.3 Johnson & Johnson
8.4 Terumo Corporation
8.5 Penumbra Inc.
8.6 Abbott Laboratories
8.7 Merit Medical Systems Inc.
8.8 W. L. Gore & Associates Inc.
8.9 Microport Scientific Corporation
8.10 Medikit Co., Ltd
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
